New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
08:47 EDTSRNESorrento Therapeutics and Morphotek sign drug development agreement
Sorrento Therapeutics subsidiary Concortis Biosystems announced a collaboration to generate novel antibody drug conjugates based on a Morphotek antibody linked to chemotherapeutic agents using Concortis' proprietary ADC Technology. Under the terms of the agreement, Sorrento will receive research fees, up-front payment, milestone payments and royalties on future net sales. Sorrento has the potential to receive up to $50M upon successful attainment of key milestones.
News For SRNE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 29, 2015
18:28 EDTSRNESorrento Therapeutics CFO Mark Durand retires
Subscribe for More Information
June 24, 2015
09:13 EDTSRNESorrento Therapeutics subsidiary receives MUMS drug designation in dogs
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use